Biography/Memoir

Sacklers… hear from opioid victims live…

On Thursday [3/10/2022], speakers are likely to make “unbelievably searing, difficult” statements, Marshall Huebner, an attorney for Purdue, said in a related hearing the day before. The court-appointed mediator requested that no member of the Sackler family be allowed to respond to comments made by victims during the hearing. It’s slated to begin at 10…

READ MORE
Biography/Memoir

Oregon… opioid settlements

The agreement – and the prior bankruptcy plan – also does not release the Sackler family from potential future criminal liability, said Oregon’s Department of Justice… It also requires the Sackler family to make a statement of regret and allow museums and other institutions to remove the Sackler name from buildings and scholarships. “Purdue Pharma’s…

READ MORE
Biography/Memoir

82 Canadian professionals request psilocybin…

About 80 health-care professionals from across the country are challenging Health Canada’s decision to reject their applications to use restricted psychedelic drugs as part of training in psilocybin-assisted psychotherapy. Hawkswell and lawyer Pope said they are ready to make a charter application if Health Canada does not retract its rejection. “You can’t have patients’ life,…

READ MORE
Biography/Memoir

…deal… opioid lawsuits

The distributors and Johnson & Johnson released statements… noting… not an admission of wrongdoing and that they strongly dispute the allegations. McKesson, Cardinal Health and AmerisourceBergen – and drug maker Johnson & Johnson announced [2/25/22] that they had… Original Article (New York Times & Stop the Drug War):J&J and drug distributors settle opioid lawsuits &…

READ MORE
Biography/Memoir

Drug arrests stayed high… imprisonment fell…

Pew Charitable Trusts: These trends indicate both an ongoing reliance on the criminal legal system to address drug misuse and that this strategy is costly and ineffective. Meaningful reductions in total drug arrests and drug-related deaths may not be achieved without shifting to a public health response that prioritizes evidence-based treatment approaches… The decline in…

READ MORE
Biography/Memoir

Compass… updates on [synthetic polymorph] psilocybin…

Compass sinks after depression therapy results… the net loss for the year [2021] was $71.7 million…  …Compass doesn’t have any meaningful revenue… continues to explore… indications and therapeutic approaches… there were 12 people in the [synthetic psilocybin polymorph] study… who exhibited suicidal behavior or thoughts, or who showed intent to harm themselves. Original Article (Green Market…

READ MORE